In this issue:
- Time-restricted eating and exercise in increased GDM risk setting
- Relationship of community belonging with diabetes incidence
- HbA1c trajectory and type 2 diabetes complication risk
- Maridebart cafraglutide for obesity
- Orforglipron in early type 2 diabetes
- Bariatric surgery vs. GLP-1 agonists for obesity
- Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy vs. RYGB
- Once-weekly semaglutide 7.2mg for obesity ± type 2 diabetes
- Proactive inpatient diabetes service model in real-world setting
Please login below to download this issue (PDF)